Published in
Wiley, Transplant Infectious Disease, 4(19), p. e12729, 2017
DOI: 10.1111/tid.12729
Links
Tools
A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study
Journal article published in 2017 by
Piñana Jl,
José Luis Piñana 
,
Juan Carlos Hernández-Boluda,
Hernández Boluda Jc,
Marisa Calabuig,
Isabel Ballester,
Manuela Marín,
Silvia Madrid,
Anabel Teruel,
Terol Mj,
María-José Terol,
David Navarro ,
Carlos Solano
,
Juan Carlos Hernández-Boluda,
Hernández Boluda Jc,
Marisa Calabuig,
Isabel Ballester,
Manuela Marín,
Silvia Madrid,
Anabel Teruel,
Terol Mj,
María-José Terol,
David Navarro ,
Carlos Solano
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 